论文部分内容阅读
目的:探究急诊治疗阵发性室上性心动过速的临床效果。方法:选取在本院治疗的阵发性室上性心动过速患者120例为研究对象,将患者分为对照组和观察组分别60例,其中对照组患者采用三磷酸腺苷二钠注射液进行治疗,观察组患者则采用普罗帕酮进行治疗,对比两组患者的临床治疗效果以及不良反应发生情况。结果:观察组治疗总有效率为93.33%,明显高于对照组的61.67%,差异有统计学意义(P<0.05)。观察组患者的不良反应发生率明显低于对照组,差异具有统计学意义(P<0.05)。结论:在阵发性室上性心动过速的临床治疗中采用普罗帕酮进行急诊治疗能够显著改善患者的临床治疗效果,降低不良反应发生率。
Objective: To investigate the clinical effect of emergency treatment of paroxysmal supraventricular tachycardia. Methods: A total of 120 patients with paroxysmal supraventricular tachycardia who were treated in our hospital were selected as study subjects. The patients were divided into control group and observation group, with 60 cases in each group. The patients in control group were treated with adenosine triphosphate disodium injection, Patients in the observation group were treated with propafenone. The clinical effects and adverse reactions of the two groups were compared. Results: The total effective rate of the observation group was 93.33%, which was significantly higher than that of the control group (61.67%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group, the difference was statistically significant (P <0.05). CONCLUSION: In the clinical treatment of paroxysmal supraventricular tachycardia, propafenone for emergency treatment can significantly improve the clinical effect of patients and reduce the incidence of adverse reactions.